Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial
- PMID: 25256180
- PMCID: PMC4329911
- DOI: 10.1161/STROKEAHA.114.006228
Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial
Abstract
Background and purpose: Evidence indicates that center volume of cases affects outcomes for both carotid endarterectomy and stenting. We evaluated the effect of enrollment volume by site on complication rates in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
Methods: The primary composite end point was any stroke, myocardial infarction, or death within 30 days or ipsilateral stroke in follow-up. The 477 approved surgeons performed >12 procedures per year with complication rates <3% for asymptomatic patients and <5% for symptomatic patients; 224 interventionists were certified after a rigorous 2 step credentialing process. CREST centers were divided into tertiles based on the number of patients enrolled into the study, with Group 1 sites enrolling <25 patients, Group 2 sites enrolling 25 to 51 patients, and Group 3 sites enrolling >51 patients. Differences in periprocedural event rates for the primary composite end point and its components were compared using logistic regression adjusting for age, sex, and symptomatic status within site-volume level.
Results: The safety of carotid angioplasty and stenting and carotid endarterectomy did not vary by site-volume during the periprocedural period as indicated by occurrence of the primary end point (P=0.54) or by stroke and death (P=0.87). A trend toward an inverse relationship between center enrollment volume and complications was mitigated by adjustment for known risk factors.
Conclusions: Complication rates were low in CREST and were not associated with center enrollment volume. The data are consistent with the value of rigorous training and credentialing in trials evaluating endovascular devices and surgical procedures.
Clinical trial registration url: http://www.clinicaltrials.gov. Unique identifier: NCT00004732.
Keywords: carotid endarterectomy; carotid stenosis; randomized controlled trial; stenting; stroke; training.
© 2014 American Heart Association, Inc.
Conflict of interest statement
N. R. Gonzales - None
B. M. Demaerschalk - None
J. H. Voeks - None
M. Tom - None
G. Howard - None
L. Garcia - None
D. Clair – Consultant: Arsenal Medical, Confluent, Endologix, Vessix Vascular, Volcano Corp.; DSMB member: Bard; Advisory Board: Boston Scientific, Medtronic
J. Barr – Shareholder: Boston Scientific, Medtronic; Consultant: Covidien
S. Orlow - None
T. G. Brott - None
References
-
- Archie JP., Jr Learning curve for carotid endarterectomy. South Med J. 1988;81:707–710. - PubMed
-
- Feasby TE, Quan H, Ghali WA. Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol. 2002;59:1877–1881. - PubMed
-
- Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the united states. N Engl J Med. 2003;349:2117–2127. - PubMed
-
- Verzini F, Cao P, De Rango P, Parlani G, Maselli A, Romano L, et al. Appropriateness of learning curve for carotid artery stenting: An analysis of periprocedural complications. J Vasc Surg. 2006;44:1205–1211. discussion 1211-1202. - PubMed
-
- Parlani G, De Rango P, Verzini F, Cieri E, Simonte G, Casalino A, et al. Safety of carotid stenting (CAS) is based on institutional training more than individual experience in large-volume centres. Eur J Vasc Endovasc Surg. 2013;45:424–430. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical